Chester County News and Community Website
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has voiced strong objections to the newly announced Medicare payment rates for its PoNS Mouthpiece, set by the Centers for Medicare & …
Helius Medical Technologies Challenges CMS Over PoNS Payment Rates Read More
NEWTOWN, PA — Harold Beck & Sons Inc. has announced William T. Fejes Jr. as its new Chief Executive Officer, succeeding Douglas C. Beck, who is retiring after 28 years at …
Harold Beck & Sons Appoints William T. Fejes Jr. as New CEO, Emphasizing Employee Ownership and Innovation Read More
NEWTOWN, PA and NEWRY, N. Ireland — EPAM Systems, Inc. (NYSE: EPAM) has announced its acquisition of First Derivative, a prominent managed services and consulting firm in the capital markets sector, …
EPAM Systems Expands Global Reach with First Derivative Acquisition Read More
NEWTOWN, PA — CenTrak has been recognized as the 2024 Company of the Year in the global healthcare real-time location systems (RTLS) industry by Frost & Sullivan. This accolade underscores CenTrak’s …
CenTrak Honored as 2024 Company of the Year by Frost & Sullivan Read More
SOUTHAMPTON, PA — Quaint Oak Bank has been awarded the Preferred Lender Program (PLP) designation by the U.S. Small Business Administration (SBA), highlighting its dedication to supporting small businesses nationwide.
Quaint Oak Bank Achieves SBA Preferred Lender Status Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has announced the appointment of Dr. Philippe Pultar as its senior medical advisor to bolster the development of APR-1051, a promising WEE1 inhibitor. …
Aprea Therapeutics Welcomes Dr. Philippe Pultar as Senior Medical Advisor Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the publication of its SEISMiC Phase 2b trial design by the European Society of Cardiology Heart Failure. The trial is exploring …
Windtree Therapeutics Publishes SEISMiC Phase 2b Trial Design for Cardiac Treatment Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has announced promising topline results from its Phase 1 study of tivoxavir marboxil, an investigational one-dose influenza treatment. Designed to inhibit the CAP-dependent …
Traws Pharma Reports Positive Phase 1 Results for Influenza Therapy Tivoxavir Marboxil Read More
YARDLEY, PA — Optinose (NASDAQ:OPTN) has appointed Terry Kohler as its new Chief Financial Officer, a strategic addition to the company’s executive team aimed at driving financial leadership and growth. Kohler …
Optinose Appoints Terry Kohler as Chief Financial Officer Read More
FEASTERVILLE, PA — Joe Hand Promotions has revealed an exciting global sports event featuring two blockbuster boxing matches: Jake Paul versus Mike Tyson, and Katie Taylor against Amanda Serrano. Set to …
Anticipation Builds as Jake Paul Faces Mike Tyson and Taylor Takes on Serrano in Major Netflix Boxing Event Read More